Literature DB >> 30461054

Direct detection from clinical sputum samples to differentiate live and dead Mycobacterium Tuberculosis.

Jie Lu1, Huiwen Zheng1, Ping Chu1, Shujing Han1, Hui Yang1, Zhongdong Wang2, Jin Shi1, Zuosen Yang3.   

Abstract

BACKGROUND: In this study, we aimed to optimize the condition of propidium monoazide (PMA) treatment for direct detection of Mycobacterium tuberculosis (MTB) from clinical specimens.
METHODS: The light exposure time, dark incubation time, bacterial load, and PMA concentration were varied to determine the optimal condition of PMA treatment.
RESULTS: Overall, the maximum ΔCq value was observed in the group receiving a light exposure time of 20 minutes, which was significantly higher than the others (P < 0.05). The prolongation of dark incubation time seemed more likely to result in greater ΔCq value, and the ΔCq values were 2.0, 4.1, 6.5, 10.1, and 12.7 cycles under dark incubation time of 10, 20, 40, 60, and 120 minutes, respectively. Alternatively, the 4+ samples exhibited favorable detection results at the application of 104 -fold dilution by PMA assay with Cq values higher than 35 cycles. Further evaluation revealed that the PMA assay showed an accordance rate of 98.0% (98/100) among clinical sputa.
CONCLUSIONS: we develop an acceptable method to directly identify the live bacteria from sputum samples. Our data demonstrate that the dark incubation plays a crucial role in the efficacy of PMA treatment for MTB.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  zzm321990Mycobacterium tuberculosiszzm321990; dead MTB; diagnosis; live MTB; propidium monoazide

Mesh:

Year:  2018        PMID: 30461054      PMCID: PMC6818545          DOI: 10.1002/jcla.22716

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  21 in total

1.  Early tuberculosis treatment monitoring by Xpert(R) MTB/RIF.

Authors:  Paolo Miotto; Sara Bigoni; Giovanni Battista Migliori; Alberto Matteelli; Daniela M Cirillo
Journal:  Eur Respir J       Date:  2012-05       Impact factor: 16.671

2.  Sputum smear microscopy: evaluation of impact of training, microscope distribution, and use of external quality assessment guidelines for resource-poor settings.

Authors:  A Van Rie; D Fitzgerald; G Kabuya; A Van Deun; M Tabala; N Jarret; F Behets; E Bahati
Journal:  J Clin Microbiol       Date:  2008-01-03       Impact factor: 5.948

3.  Detection of mRNA by reverse transcription-PCR as an indicator of viability in Escherichia coli cells.

Authors:  G E Sheridan; C I Masters; J A Shallcross; B M MacKey
Journal:  Appl Environ Microbiol       Date:  1998-04       Impact factor: 4.792

4.  Utility of propidium monoazide viability assay as a biomarker for a tuberculosis disease.

Authors:  Vladyslav Nikolayevskyy; Paolo Miotto; Edita Pimkina; Yanina Balabanova; Irina Kontsevaya; Olga Ignatyeva; Alessandro Ambrosi; Girts Skenders; Arvydas Ambrozaitis; Alexander Kovalyov; Anna Sadykhova; Tatiana Simak; Andrey Kritsky; Svetlana Mironova; Olesya Tikhonova; Yulia Dubrovskaya; Yulia Rodionova; Daniela Cirillo; Francis Drobniewski
Journal:  Tuberculosis (Edinb)       Date:  2014-12-09       Impact factor: 3.131

5.  A highly efficient Ziehl-Neelsen stain: identifying de novo intracellular Mycobacterium tuberculosis and improving detection of extracellular M. tuberculosis in cerebrospinal fluid.

Authors:  Ping Chen; Ming Shi; Guo-Dong Feng; Jia-Yun Liu; Bing-Ju Wang; Xiao-Dan Shi; Lei Ma; Xue-Dong Liu; Yi-Ning Yang; Wen Dai; Ting-Ting Liu; Ying He; Jin-Ge Li; Xiao-Ke Hao; Gang Zhao
Journal:  J Clin Microbiol       Date:  2012-01-11       Impact factor: 5.948

6.  Propidium monoazide and Xpert MTB/RIF to quantify Mycobacterium tuberculosis cells.

Authors:  Xavier A Kayigire; Sven O Friedrich; Miriam N Karinja; Lize van der Merwe; Neil A Martinson; Andreas H Diacon
Journal:  Tuberculosis (Edinb)       Date:  2016-09-04       Impact factor: 3.131

Review 7.  Tuberculosis diagnostics in 2015: landscape, priorities, needs, and prospects.

Authors:  Madhukar Pai; Marco Schito
Journal:  J Infect Dis       Date:  2015-04-01       Impact factor: 5.226

8.  Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology.

Authors:  Danica Helb; Martin Jones; Elizabeth Story; Catharina Boehme; Ellen Wallace; Ken Ho; JoAnn Kop; Michelle R Owens; Richard Rodgers; Padmapriya Banada; Hassan Safi; Robert Blakemore; N T Ngoc Lan; Edward C Jones-López; Michael Levi; Michele Burday; Irene Ayakaka; Roy D Mugerwa; Bill McMillan; Emily Winn-Deen; Lee Christel; Peter Dailey; Mark D Perkins; David H Persing; David Alland
Journal:  J Clin Microbiol       Date:  2009-10-28       Impact factor: 5.948

9.  Use of propidium monoazide for live/dead distinction in microbial ecology.

Authors:  Andreas Nocker; Priscilla Sossa-Fernandez; Mark D Burr; Anne K Camper
Journal:  Appl Environ Microbiol       Date:  2007-06-22       Impact factor: 4.792

Review 10.  Degradation of RNA in bacteria: comparison of mRNA and stable RNA.

Authors:  Murray P Deutscher
Journal:  Nucleic Acids Res       Date:  2006-02-01       Impact factor: 16.971

View more
  3 in total

1.  New insights into the kinetics of bacterial growth and decay in pig manure-wheat straw aerobic composting based on an optimized PMA-qPCR method.

Authors:  Jinyi Ge; Guangqun Huang; Xiaoxi Sun; Hongjie Yin; Lujia Han
Journal:  Microb Biotechnol       Date:  2019-03-05       Impact factor: 5.813

2.  An aptasensor for the detection of Mycobacterium tuberculosis secreted immunogenic protein MPT64 in clinical samples towards tuberculosis detection.

Authors:  Marzhan Sypabekova; Kanat Dukenbayev; Anna Tsepke; Akmaral Akisheva; Nurlan Oralbayev; Damira Kanayeva
Journal:  Sci Rep       Date:  2019-11-07       Impact factor: 4.379

3.  A Novel Propidium Monoazide-Based PCR Assay Can Measure Viable Uropathogenic E. coli In Vitro and In Vivo.

Authors:  Albert S Lee; Olivia K Lamanna; Kenji Ishida; Elaise Hill; Andrew Nguyen; Michael H Hsieh
Journal:  Front Cell Infect Microbiol       Date:  2022-02-01       Impact factor: 5.293

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.